Document:

EX-10.1

 Exhibit 10.1 

December 11th, 2014 
 Rodney O. Martin, Jr. 

Voya Financial, Inc. 
 230 Park Avenue 

13th Floor 

New York, N.Y. 10169 
 Re: Employment
Agreement  
 Dear Rod: 
 This is your
EMPLOYMENT AGREEMENT, dated as of December 11th, 2014 (the “Agreement”) with Voya Financial, Inc., a Delaware corporation (the “Company”). It sets forth the terms of your employment with the Company and its
subsidiaries from time to time and replaces and supersedes in its entirety your Amended and Restated Employment Agreement, dated July 25, 2013, with ING U.S., Inc., and ING North America Insurance Corporation (the “Prior
Agreement”) other than Section 3(c) of the Prior Agreement and such other Sections and Sub-Sections of the Prior Agreement as are necessary to give effect to Sections 3(c) (including, but not limited to, Section 3(f) and the
definition of “Cause” in Section 5(d)(1) and “Good Reason” in Section 5(e)(1)), which will continue in full force and effect in accordance with its terms; provided however, that, solely for purposes of Sections
3(c), 3(f) and 5(g) of the Prior Agreement, execution of this Agreement will be deemed an extension of the Prior Agreement through December 31, 2016. 

1. Your Positions, Performance and Other Activities 

(a) Positions. During the Term (as defined herein), you will be employed in the position of Chief Executive Officer of the Company and
serve as the Chairman of the Board of Directors of the Company (the “Board”). 
 (b) Authority, Responsibilities and
Reporting. You will have the authority, responsibilities and reporting relationships that correspond to your position as the senior-most executive officer of the Company. Also, you will have any particular authority, responsibilities and
reporting relationships consistent with your position that the Board may assign or delegate to you from time to time. 
 (c)
Performance. During your employment, you will devote your entire business time, attention and efforts to the responsibilities of your employment under this Agreement and will use good faith efforts to discharge your responsibilities to the
best of your ability. However, you will be permitted to do the activities stated in Section 1(e). 
 (d) Place of Employment.
Your place of employment will be New York, New York, unless mutually agreed by the parties. The Company may, however, require you to travel on business to an extent consistent with your position. 

(e) Other Activities. During your employment, you will not render any business, commercial or professional services to any entity that
is not a member of the group comprised of the Company and its affiliates (together, the “Group”). However, you may: 
 (1)
serve on a for-profit corporate board; 
 (2) serve on civic or charitable boards; and 

(3) manage personal investments; 

 as long as (A) your activities described in clauses (1), (2) and (3) above do not
(individually or in the aggregate) interfere with your performance of the responsibilities of your employment under this Agreement and (B) any service on a for-profit corporate board is subject to pre-approval by the Board or as delegated by
the Board to one of its committees, which is not to be unreasonably withheld based on the facts and circumstances at the time. 
 2. Term 

The term of your employment under this Agreement shall commence on the date set forth above (your “Effective Date”) and,
unless terminated earlier as provided in Section 5 of this Agreement, end on December 31, 2018 (the “Term”); provided, however, that, prior to July 1, 2018, you and the Company may mutually agree to
extend the Term by an additional year to December 31, 2019. Notwithstanding anything herein to the contrary, in the event that you and the Company agree that this Agreement shall expire as of the end of the Term, such expiration shall not
constitute a termination by the Company without Cause or by you for Good Reason. References in this Agreement to “your employment” are to your employment under this Agreement during the Term. 

3. Your Compensation 
 (a) Base
Salary. During your employment, you will receive an annual base salary (your “Salary”) in an amount not less than $1,000,000, payable semi-monthly in accordance with the Company’s regular payroll practices. 

(b) Incentive Compensation Plan. During your employment, starting with fiscal year 2015, you will be eligible to participate in the
Incentive Compensation Plan (as it may be amended from time to time, the “ICP”) for each fiscal year of the Company beginning during your employment. Your target bonus opportunity under the ICP will be equal to 200% of your Salary
(“ICP Target Opportunity”) with any actual award (higher or lower) determined by the Compensation and Benefits Committee of the Board (the “Committee”) based on the Company’s actual performance, subject to the
terms and conditions of the ICP. Your ICP awards shall be subject to terms and conditions no less favorable than those applicable to other senior executive officers of the Company with respect to their annual incentive award opportunities. 

(c) Long-Term Incentive Plans. During your employment, starting in fiscal year 2015, you will be eligible to receive a long-term
incentive award opportunity in each fiscal year of the Company beginning during your employment (which initial grant shall be made no later than such date in calendar year 2015 when long-term incentive award grants are made to other senior executive
officers), with a target value equal to $5,500,000 (“Target LTI Opportunity”) with any actual award (higher or lower) determined by the Committee based on the Company’s actual performance, subject to the terms and conditions of
the applicable long-term incentive plan of the Company under which such awards are granted and with the form(s) of the award (e.g., performance units, restricted stock units, options or other awards) and performance metrics to be determined by the
Committee in its discretion. 
 (d) Benefit Plans. During your employment, you will be entitled to participate in each of the
Company’s employee benefit and welfare plans, including plans providing retirement benefits or medical, dental, hospitalization, life or disability insurance, on a basis that is at least as favorable as that provided to other senior executives
of the Company generally. 
 4. Other Employee Benefit Provisions. 

(a) Paid Time-Off (PTO) Bank. You will be entitled to an annual PTO Bank on a basis that is at least as favorable as that provided to
other senior executive officers of the Company generally. The PTO Bank can be used for absences for vacation, personal time, family illness and individual sick days. 

(b) Business Expenses. You will be reimbursed for all reasonable business and entertainment expenses incurred by you in performing the
responsibilities of your employment under this Agreement, subject to the Company’s normal reimbursement policy for its senior executives generally. 

(c) Indemnification. To the fullest extent permitted by law, the Company will indemnify you against any actual or threatened action,
suit or proceeding, whether civil, criminal, administrative or investigative, arising by 

  
 2 

 
reason of your status as a director, officer, employee and/or agent of the Company or any of its affiliates during your employment. In addition, to the fullest extent permitted by law, the
Company will pay or reimburse any expenses, including reasonable attorney’s fees, you incur in investigating and defending any actual or threatened action, suit or proceeding for which you may be entitled to indemnification under this
Section 4(c). However, you agree to repay any expenses paid or reimbursed by the Company if it is ultimately determined that you are not legally entitled to be indemnified by the Company. If the Company’s ability to make any payment
contemplated by this Section 4(c) depends on an investigation or determination by the Board (or the board of directors of any past, present or future affiliate of the Company), at your request the Company will use its best efforts to cause the
investigation to be made (at the Company’s expense) and to have the Board (or such other board) reach a determination as soon as reasonably possible. The indemnification and payment or reimbursement of expenses provided by the Company pursuant
to this Agreement shall not be deemed exclusive of any other rights to which you may be entitled under any officers’ and directors’ liability insurance policies, agreements, the Company’s articles of incorporation, charter or bylaws,
or other laws (common or statutory), as to your action as a director, officer, employee and/or agent of the Company or any past, present or future affiliate. 

(d) SERP. You and the Company agree that, for purposes of Section 5 (Forfeiture of Benefits) of the Company’s Supplemental
Executive Retirement Plan (Amended and Restated December 2011), you will only be considered to have “engage[d] in competition with the Company” if you breach your obligations under Section 7(d) of this Agreement. 

(e) Equity Awards. You and the Company agree that, with respect to any equity awards granted to you by the Company after the Effective
Date: 
 (i) To the extent any form of award agreement adopted by the Company contains post-employment restrictive covenants (such as, by
way of example only, those contained in Section 8.1 of the 2014 Award Agreement under the Company’s 2013 Omnibus Employee Incentive Plan (the “2014 Award Agreement”)), your award agreement for awards granted after the
Effective Date will reference Section 7 of this Agreement in lieu of those post-employment restrictive covenants and, in any event, Section 7 of this Agreement shall supersede any provisions in such award agreement made after the Effective
Date that is in conflict with Section 7. 
 (ii) To the extent any form of award agreement adopted by the Company contains provisions
for adjustment or cancellation of outstanding awards (such as, by way of example only, the hold back provisions contained in Section 4.2 of the 2014 Award Agreement), your award agreement for awards granted after the Effective Date will provide
that such actions shall be authorized only in the event of conduct or acts triggering the claw back of awards (such as, by way of example only, those provisions contained in Section 4.1 of the 2014 Award Agreement) set forth in such award
agreement; provided that such awards granted after the Effective Date shall also be subject to any executive recoupment policy adopted by the Company in compliance with law, regulations or stock exchange listing conditions. 

5. Early Termination of Your Employment. 

(a) No Reason Required. You or the Company may terminate your employment early at any time for any reason, or for no reason, subject to
compliance with Section 5(b) of this Agreement. This includes early termination by the Company with or without Cause (as defined below) and early termination by you for Good Reason (as defined below) or any other reason. 

(b) Advance Notice Required. To terminate your employment before the end of the Term (as may be extended for one year by mutual consent
of the parties as set forth in Section 2 of this Agreement), either you or the Company must provide notice to the other (a “Termination Notice”). You and the Company agree to provide 90 days’ advance Termination Notice of
any early termination, unless your employment is terminated by the Company for Cause or because of your Disability (as defined below) or death. The Company may elect to place you on paid leave for all or part of the advance notice period. 

(c) Termination Date. The effective date of early termination of your employment will be: 

(1) 90 days after Termination Notice is given, unless your employment is terminated by the Company for Cause or by your
Disability or death, 

  
 3 

 (2) the time Termination Notice is given, if your employment is terminated by the
Company for Cause, although the Company may provide a later effective date in the Termination Notice, 
 (3) 30 days after
Termination Notice is given, if your employment is terminated because of your Disability, or 
 (4) the time of your death,
if your employment is terminated because of your death. 
 (d) Termination by the Company for Cause.  

(1) “Cause” means any of the following: 

(A) Your willful failure to perform substantially your responsibilities to the Company under this Agreement, after written
demand for substantial performance has been given by the Board that specifically identifies how you have not substantially performed your responsibilities. Cause does not, however, include failure resulting from your incapacity due to mental or
physical illness or injury or from any permitted leave required by law or any failure after the Company gives Termination Notice other than for Cause or Disability. 

(B) Your engagement in illegal conduct or in gross negligence or willful misconduct, in any case, that is materially and
demonstrably injurious to the Company. 
 (C) Your material breach of any provision of Section 7. 

For purposes of this definition, no act or failure to act on your part shall be considered “willful” unless it is done, or omitted
to be done, by you in bad faith or without reasonable belief that the action or omission was in the best interests of the Company. Any act or omission by you based on authority given pursuant to a resolution duly adopted by the Board or on the
advice of counsel for the Company will be deemed made in good faith and in the best interests of the Company. Your employment may only be terminated for Cause by a duly adopted resolution of the Board. 

(2) To terminate your employment for Cause, all of the following must be satisfied: 

(A) The Company must give you notice and a 30-day period to cure the first event constituting Cause. (For the avoidance of
doubt, neither subsection (A) nor (B) above requires the Company to give you more than one cure-opportunity during your employment.) 

(B) The Company must provide you with a Termination Notice that (i) states that you are being terminated for Cause,
(ii) indicates the subsection above that the Company is relying on, and (iii) provides reasonable detail of the facts providing the basis for that reliance. (The failure to include any fact in a Termination Notice that contributes to a
showing of Cause does not preclude the Company from asserting that fact in enforcing its rights under this Agreement.) 

(C) The Company must provide you with a right to be heard by the Committee. 

(D) In the event such termination occurs after a “Change in Control” (as defined in the Voya Financial, Inc.
2014 Employee Omnibus Incentive Plan, as it may be amended from time to time), the decision to terminate your employment for Cause must be approved by two-thirds of the members of the board of directors of the ultimate parent company of the Company
following the Change in Control. 

  
 4 

 (e) Termination by you for Good Reason. 

(1) “Good Reason” means a material breach by the Company or by the Board of their obligations to you under
this Agreement, including but not limited to: 
 (A) a reduction in your Salary, ICP Target Opportunity, or Target LTI
Opportunity or any failure to pay compensation or other amounts due under the Agreement; 
 (B) failure to nominate you to
serve on the Board and maintain you in the positions contemplated by Section 1(a), or any material reduction or other materially adverse action related to your authority, responsibilities or duties, or assignment of duties inconsistent with
those contemplated by Sections 1(a) and (b); 
 (C) the relocation of your principal office more than 50 miles from the New
York City metropolitan area; or 
 (D) following a Change in Control only, no longer being Chief Executive Officer and
Chairman of a publicly-traded entity. 
 (2) To terminate your employment for “Good Reason,” both of the following
must be satisfied: 
 (A) You must give the Company written notice of your intent to terminate your employment for Good
Reason within 30 days after your knowledge of the occurrence of the breach constituting Good Reason and give the Company a 30-day cure period in which to cure such breach. 

(B) You must provide the Company with a Termination Notice that (i) states that you are terminating your employment for
Good Reason and (ii) provides reasonable detail of the facts providing the basis for your Good Reason termination. (The failure to include any fact in a Termination Notice that contributes to a showing of Good Reason does not preclude you from
asserting that fact in enforcing your rights under this Agreement.) 
 (f) Termination on Disability or Death. 

(1) The term “Disability” has the same meaning as set forth in the Company’s long-term disability plan.
If the Company determines in good faith that your Disability has occurred, it may give you Termination Notice. If within 30 days following the Termination Notice you do not return to full-time performance of your responsibilities, your employment
will terminate. If you do return to full-time performance in that 30-day period, the Termination Notice will be cancelled for all purposes of this Agreement. 

(2) Your employment will terminate automatically on your death. 

6. The Company’s Obligations in Connection With Your Termination 

(a) General Effect. On termination in accordance with Section 5 of this Agreement, your employment will end and the Company will
have no further obligations to you under this Agreement, except as provided in this Section 6. The payments and benefits as provided in this Section 6 will not affect your rights under any other agreement you may have with the Company at
the end of your employment (except as this Section 6 specifically states) including, without limitation, under Section 3(c) of the Prior Agreement. 

(b) For Cause. If the Company terminates your employment for Cause prior to the end of the Term: 

  
 5 

 (1) The Company will pay you (A) your unpaid Salary through the end of your
employment, (B) your Salary for any accrued PTO that you have not taken through the end of your employment, (C) any accrued expense reimbursements or other accrued vested cash entitlements through the end of your employment and
(D) any earned but unpaid award under the ICP for a fiscal year ending before the end of your employment (together, your “Accrued Compensation”). 

(2) The Company will timely pay you any amounts and provide you any benefits that are required, or to which you are entitled,
under any plan, contract or arrangement of the Company other than those described in this Agreement (including any unpaid deferred compensation and other cash or in kind compensation accrued by you through the end of your employment (e.g., 401(k)
matching contributions, deferred compensation spillover contributions)) in accordance with the existing terms and conditions of, and to the extent and at the times provided for in, the applicable plan, contract or arrangement (together, the
“Other Benefits”). 
 (c) By you for other than Good Reason. If you voluntarily terminate your employment for other
than Good Reason prior to the end of the Term: 
 (1) The Company will pay you your Accrued Compensation and will provide you
with the Other Benefits. 
 (2) Subject to Section 6(g) below: 

(A) If your employment terminates on or prior to December 31, 2016, during the two-year period immediately following your
termination of employment, each outstanding unvested restricted stock unit or performance share unit (and any other equity awards) granted following the Effective Date and held by you will continue to vest and be settled and shares or the equivalent
(as the case may be) delivered (and in the case of stock options vest and become exercisable) on the scheduled dates set forth in the agreements evidencing such awards without regard to any provisions regarding the effect of a termination of
employment on such awards but otherwise subject to the terms and conditions set forth therein; provided that on the second anniversary of the date of the termination of your employment, each outstanding award will expire and you will have no further
rights thereunder (other than rights with respect to settlement, share delivery and/or exercise of vested awards). 
 (B) If
your employment terminates on or after January 1, 2017, following your termination of employment, each outstanding unvested restricted stock units or performance share units (and any other equity awards) granted following the Effective Date and
held by you will continue to vest and be settled (in whole or in part) and shares delivered (and in the case of stock options vest and become exercisable) on the scheduled dates set forth in the agreements evidencing such awards without regard to
any provisions regarding the effect of a termination of employment on such awards but otherwise subject to the terms and conditions set forth therein; provided, that, the portion of each such award that will vest and be settled (and in the case of
stock options vest and become exercisable) on such scheduled date will be equal to the product determined by multiplying (i) the shares that otherwise would have been vested (and/or become exercisable) on the original scheduled vesting date(s)
by (ii) a fraction the numerator of which is the sum of (x) the number of full and partial months which have elapsed from the grant date of the award to the date of the termination of your employment and (y) 24 months (provided the
sum of (x) and (y) may not exceed the total number of months during the original vesting period under the award) and the denominator of which is the total number of months during the original vesting period under the award. On the
date of the termination of your employment, any remaining portion of such awards will expire and you will have no further rights thereunder (other than rights with respect to settlement and/or exercise of vested awards). 

This Section 6(c)(2) shall not apply to awards granted prior to the Effective Date (which shall continue to be subject to
their terms) and the parties agree that if an equity-based award not referenced in paragraphs (A) and (B) above is granted to you, you and the Company shall use the premises set forth in paragraphs (A) and (B) above to treat such
awards in a substantially equivalent manner. Furthermore, solely for the avoidance of doubt, the parties agree that the examples of determination of the vesting of 

  
 6 

 
equity-based awards attached as Annex I to this Agreement reflect the intended application of this Section 6(c)(2), and this Agreement shall not be interpreted in any manner that
would be inconsistent with those examples. 
 (d) Without Cause or by you for Good Reason Prior to a Change in Control. Subject to
Section 6(g) below, if, during the Term, the Company terminates your employment without Cause or you terminate your employment for Good Reason: 

(1) The Company will pay you your Accrued Compensation and will provide you with the Other Benefits. 

(2) The Company will pay you your Pro-Rata ICP Award. Your “Pro-Rata ICP Award” means your award under the ICP
for the fiscal year of the Company during which Termination Notice is given, determined as set forth in Section 3(b) of this Agreement, multiplied by a fraction the numerator of which is the number of days of your employment since the
fiscal year ending before Termination Notice is given and the denominator of which is 365. 
 (3) The Company will pay you a
lump sum severance payment in an amount equal to (A) your Salary plus your ICP Award Opportunity (not taking into account any reductions to those amounts which would constitute Good Reason) multiplied by (B) two (2). 

(4) If you elect continuation coverage under the Company’s group health plan(s) pursuant to Section 4980B of the
Internal Revenue Code of 1986, as amended (“COBRA”), the Company will reimburse you for your premiums for 18 months. 

(5) Any restricted stock units, performance share units, restricted stock, stock options or any other equity-based awards
granted to you after the Effective Date will continue to be vested and settled and shares delivered (or be exercisable) on the scheduled dates set forth in the agreements evidencing such awards without regard to any provisions regarding the effect
of a termination of employment on such awards but otherwise subject to the terms and conditions set forth therein. 
 (e) Without Cause
or by you for Good Reason Within Two Years Following a Change in Control. Subject to Section 6(g) and 6(i) below, if, during the Term, the Company terminates your employment without Cause or you terminate your employment for Good Reason
within two (2) years following a Change in Control: 
 (1) The Company will pay you your Accrued Compensation and will
provide you with the Other Benefits. 
 (2) The Company will pay you your CIC Pro-Rata ICP Award. Your “CIC Pro-Rata
ICP Award” will be equal to your ICP Award Opportunity multiplied by a fraction the numerator of which is the number of days of your employment since the fiscal year ending before Termination Notice and the denominator of which is
365. 
 (3) The Company will pay you a lump sum severance payment in an amount equal to (A) your Salary plus your ICP
Award Opportunity (not taking into account any reductions to those amounts which would constitute Good Reason) multiplied by (B) two (2). 

(4) If you elect continuation coverage under the Company’s group health plan(s) pursuant to Section 4980B of the
Internal Revenue Code of 1986, as amended ( “COBRA”), the Company will reimburse you for your premiums for 18 months, on a monthly basis within 30 days following your payment of such premium. 

(5) Any restricted stock units, performance share units, restricted stock, stock options or any other equity-based awards
granted to you after the Effective Date will continue to be vested and settled and shares delivered (or be exercisable) on the scheduled dates set forth in the agreements evidencing such awards without regard to any provisions regarding the effect
of a termination of employment on 

  
 7 

 
such awards but otherwise subject to the terms and conditions set forth therein; provided, however, to the extent such treatment would not cause a violation of Section 409A of the
Code (as defined below), if the award agreement for any outstanding restricted stock unit, performance share unit or other equity-based award granted to you after the Effective Date provides for any accelerated vesting or settlement, to the extent
applicable to you, such provisions will supersede the vesting and settlement timing set forth in this Section 6(e)(5). 
 (f) For Your
Disability or Death. If, during your employment, your employment terminates as a result of your death or Disability: 

(1) The Company will pay your Accrued Compensation and will provide you with the Other Benefits. 

(2) The Company will pay you and/or your estate your Pro-Rata ICP Award. 

(3) Equity-based awards shall be treated pursuant to the terms of their respective award agreements. 

(g) Condition. The Company will not be required to make the payments and provide the benefits stated in Section 6(c)(2),
6(d)(2)-(5) or 6(e)(2)-(5) of this Agreement nor, in the event of a termination of your employment by the Company without Cause or by you for Good Reason, in Section 3(c) of the Prior Agreement, unless you execute and deliver to the
Company an agreement releasing the Company and its affiliates from all liability (other than the payments and benefits contemplated by this Agreement) no later than twenty-one (21) days following your receipt of such release agreement and have
not revoked such release during any applicable revocation period. This release agreement will be substantially in the form attached as Annex A to this Agreement and will be provided to you no later than seven (7) days following your date
of termination; provided, however, that if your termination of employment occurs within two (2) years following a Change in Control, your obligation under this Section 6(g) will be subject to the Company’s execution and
delivery to you of an agreement (substantially in the form attached as Annex B to this Agreement) releasing you from all liability (other than the post-employment obligations contemplated by this Agreement) no later than the end of any
revocation period applicable to your release agreement in respect of the Company and its affiliates, and if, as a result of the Company’s failure to execute and deliver to you an agreement substantially in the form of Annex B, such
obligation on your part is not triggered, you shall receive the payments and benefits stated in Section 6(e)(2)-(5) of this Agreement at the time(s) provided in Section 6(h) of this Agreement notwithstanding your failure to deliver a
release agreement or your revocation of such release agreement. 
 (h) Timing and Payment. Provided you have timely delivered the
release described in Section 6(g) and have not revoked such release during any applicable revocation period and you are in compliance with Section 7 of this Agreement, (i) the cash severance payment set forth in Section 6(d)(3)
or Section 6(e)(3), as applicable, will be paid in a lump sum on the fortieth (40th) day after your date of termination of employment, (ii) the Pro-Rata ICP Award will be paid pursuant to Section 6(d)(2) as soon as practicable
following determination by the Company of achievement of the applicable performance goals, provided that, in any event any such Pro-Rata ICP Award shall be paid no later than 30 days following such determination or at the same time as other
employees are paid under the ICP if earlier, (iii) the CIC Pro-Rata ICP Award shall be paid pursuant to Section 6(e)(2) in a lump sum on the fortieth (40th) day after your date of termination of employment, (iv) the Transaction
Incentive Award amounts described in Section 3(c) of the Prior Agreement payable on termination as provided in the Prior Agreement (subject to the release described in Section 6(g) of this Agreement, not the release included in the Prior
Agreement) will be paid in a lump sum on the fortieth (40th) day after your date of termination of employment and (v) restricted stock units, performance share units or other equity awards granted after the Effective Date will be settled
as set forth in Section 6(c)(2), 6(d)(5) or 6(e)(5), as applicable. However, any deferred compensation owed you, as well as any Other Benefits will be paid and/or provided as stated in the applicable plan. The Accrued Compensation shall be paid
within thirty (30) days following your date of termination of employment or, in respect of any earned but unpaid award under the ICP for a fiscal year ending before the end of your employment at the same time as other employees are paid under
the ICP. 

  
 8 

 (i) Tax Provision. Notwithstanding anything herein to the contrary, in the event that an
independent, nationally recognized, accounting firm which shall be designated by the Company with your written consent (which consent shall not be unreasonably withheld) (the “Accounting Firm”) shall determine that any payment or
distribution of any type to or for the your benefit made by the Company, by any of its affiliates, by any person who acquires ownership or effective control or ownership of a substantial portion of the Company’s assets (within the meaning of
Section 280G of the Code and the regulations thereunder) or by any affiliate of such person, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (collectively, the “Total
Payments”), would be subject to the excise tax imposed by Section 4999 of the Internal Revenue Code of 1986, as amended (the “Code”) or any interest or penalties with respect to such excise tax (such excise tax,
together with any such interest or penalties, are collectively referred to as the “Excise Tax”), then the Accounting Firm shall determine whether such payments or distributions or benefits shall be reduced to such lesser amount as
would result in no portion of such payments or distributions or benefits being subject to the Excise Tax. Such reduction shall occur if and only to the extent that it would result in you retaining a larger amount, on an after-tax basis (taking into
account federal, state and local income taxes, employment, social security and Medicare taxes, the imposition of the Excise Tax and all other taxes, determined by applying the highest marginal rate under Section 1 of the Code and under state
and local laws which applied (or is likely to apply) to your taxable income for the tax year in which the transaction which causes the application of Section 280G of the Code occurs, or such other rate(s) as the Accounting Firm determines to be
likely to apply to you in the relevant tax year(s) in which any of the Total Payments is expected to be made) than if you received all of the Total Payments. If the Accounting Firm determines that you would not retain a larger amount on an after-tax
basis if the Total Payments were so reduced, then you shall retain all of the Total Payments. If the Total Payments are to be reduced, the reduction shall occur in the following order: (1) reduction of cash payments for which the full amount is
treated as a “parachute payment” (as defined under Section 280G of the Code and the regulations thereunder); (2) cancellation of accelerated vesting (or, if necessary, payment) of cash awards for which the full amount is not
treated as a parachute payment; (3) reduction of any continued employee benefits; and (4) cancellation or reduction of any accelerated vesting of equity awards. In selecting the equity awards (if any) for which vesting will be cancelled or
reduced under clause (4) of the preceding sentence, awards shall be selected in a manner that maximizes the after-tax aggregate amount of reduced Total Payments provided to you, provided that if (and only if) necessary in order to avoid the
imposition of an additional tax under Section 409A of the Code (as defined below), awards instead shall be selected in the reverse order of the date of grant. If two or more equity awards are granted on the same date, each award will be reduced
on a pro-rata basis. You and the Company shall furnish such documentation and documents as may be necessary for the Accounting Firm to perform the requisite Section 280G of the Code computations and analysis, and the Accounting Firm shall
provide a written report of its determinations, hereunder, including detailed supporting calculations. If the Accounting Firm determines that aggregate Total Payments should be reduced as described above, it shall promptly notify you and the Company
to that effect. In the absence of manifest error, all determinations made by the Accounting Firm under this Section 6(i) shall be binding on you and the Company and shall be made as soon as reasonably practicable and in no event later than
fifteen (15) days following the later of your date of termination of employment or the date of the transaction which causes the application of Section 280G of the Code. The Company shall bear all costs, fees and expenses of the Accounting
Firm. 
 To the extent requested by you, the Company shall cooperate with you in good faith in valuing, and the Accounting Firm shall take
into account the value of, services to be provided by you (including your agreeing to refrain from performing services pursuant to a covenant not to compete) before, on or after the date of the transaction which causes the application of
Section 280G of the Code such that payments in respect of such services may be considered to be “reasonable compensation” within the meaning of Q&A-9 and Q&A-40 to Q&A-44 of the final regulations under Section 280G of
the Code and/or exempt from the definition of the term “parachute payment” within the meaning of Q&A-2(a) of such final regulations in accordance with Q&A-5(a) of such final regulations. 

If it is ultimately determined (by IRS private letter ruling or closing agreement, court decision or otherwise) that your Total Payments were
reduced by too much or by too little in order to accomplish the purpose of this Section 6(i), you and the Company shall promptly cooperate to correct such underpayment or overpayment in a manner consistent with the purpose of this
Section 6(i). 

  
 9 

 7. Your Obligations to the Company in Connection With Your Termination 

(a) General Effect. This Section 7 applies during your employment and for some time after your employment ends. This Section uses
the following defined terms: 
 “Competitive Enterprise” means any business enterprise that either
(1) engages in any activity that competes anywhere with any activity that the Company or any of its subsidiaries is then engaged in or (2) holds a 10% or greater equity, voting or profit participation interest in any enterprise that
engages in such a competitive activity.  
 “Client” means any client or prospective client of the
Group to whom you provided services, or for whom you transacted business, or whose identity became known to you in connection with your relationship with or employment by the Company. 

“Proprietary Information” means confidential or proprietary information, knowledge or data concerning
(1) the Group’s businesses, strategies, operations, financial affairs, organizational matters, personnel matters, budgets, business plans, marketing plans, studies, policies, procedures, products, ideas, processes, software systems, trade
secrets and technical know-how, (2) any other matter relating to the Company and (3) any matter relating to clients of the Group or other third parties having relationships with the Group. Proprietary Information includes
(1) information regarding any aspect of your tenure as an employee of the Group or the termination of your employment, (2) the names, addresses, and phone numbers and other information concerning clients and prospective clients of the
Group, (3) investment techniques and trading strategies used in, and the performance records of, client accounts or other investment products, and (4) information and materials concerning the personal affairs of employees of the Group. In
addition, Proprietary Information may include information furnished to you orally or in writing (whatever the form or storage medium) or gathered by inspection, in each case before or after the date of this Agreement. However, Proprietary
Information does not include information (1) that was or becomes generally available to you on a non-confidential basis, if the source of this information was not reasonably known to you to be bound by a duty of confidentiality, or
(2) that was or becomes generally available to the public, other than as a result of a disclosure by you, directly or indirectly. 

“Solicit” means any direct or indirect communication of any kind, regardless of who initiates it, that in any
way invites, advises, encourages or requests any person to take or refrain from taking any action. 
 (b) Your Importance to the Company
and the Effect of this Section 7. You acknowledge that: 
 (1) In the course of your involvement in the Group’s
activities, you will have access to Proprietary Information and the Group’s client base and will profit from the goodwill associated with the Group. On the other hand, in view of your access to Proprietary Information and your importance to the
Company, if you compete with the Company or any of its subsidiaries for some time after your employment, the Company and its subsidiaries will likely suffer significant harm. In return for the benefits you will receive from the Company and to induce
the Company to enter into this Agreement, and in light of the potential harm you could cause the Company, you agree to the provisions of this Section 7. The Company would not have entered into this Agreement if you did not agree to this
Section 7. 
 (2) This Section 7 limits your ability to earn a livelihood in a Competitive Enterprise and your
relationships with Clients. You acknowledge, however, that complying with this Section 7 will not result in severe economic hardship for you or your family. 

(c) Use, Disclosure and Return of Proprietary Information. You will obtain or create Proprietary Information in the course of your
involvement in the Group’s activities and may already have Proprietary Information. You agree that the Proprietary Information is the exclusive property of the Group, and you agree to use and disclose Proprietary Information, both during and
after termination of your employment, only for the Group’s benefit and in accordance with any restrictions placed on its use or disclosure by the Group. In addition, nothing in 

  
 10 

 
this Agreement will operate to weaken or waive any rights the Company may have under statutory or common law, or any other agreement, to the protection of trade secrets, confidential business
information and other confidential information. When your employment terminates, you agree to return to the Company all Proprietary Information, including all notes, mailing lists, rolodexes and computer files that contain any Proprietary
Information. 
 (d) Non-Competition. During your employment and for the 24-month period following termination of your employment for
any reason (the “Restricted Period”), you will not directly or indirectly: 
 (1) hold a 2% or greater
equity, voting or profit participation interest in a Competitive Enterprise; or 
 (2) associate (including as a director,
officer, employee, partner, consultant, agent or advisor) with a Competitive Enterprise and in connection with your association engage, or directly or indirectly manage or supervise personnel engaged, in any activity: 

(A) that is substantially related to any activity that you were engaged in, 

(B) that is substantially related to any activity for which you had direct or indirect managerial or supervisory
responsibility, or 
 (C) that calls for the application of specialized knowledge or skills substantially related to those
used by you in your activities; 
 in each case, for the Group at any time during your employment. 

(e) Non-Solicitation of Clients. Until the end of the Restricted Period, you will not attempt to: 

(1) Solicit any Client to transact business with a Competitive Enterprise or to reduce or refrain from doing any business with
the Group, 
 (2) transact business with any Client that would cause you to be a Competitive Enterprise or to reduce or
refrain from doing any business with the Group, or 
 (3) interfere with or damage any relationship between the Group and a
Client. 
 (f) Non-Solicitation of Company Employees. Until the end of the Restricted Period, you will not attempt to Solicit anyone
who is then an employee of the Group (or who was an employee of the Group within the prior six months) to resign from the Group or to apply for or accept employment with any Competitive Enterprise. For the avoidance of doubt, it shall not be a
violation of this Section 7(f) for you to Solicit any employees of the Group through a non-targeted general advertisement or to provide references for any employees of the Group. 

(g) Notice to New Employers. Before you either apply for or accept employment with any other person or entity while any of
Section 7(d), (e) or (f) is in effect, you will provide the prospective employer with written notice of the provisions of this Section 7 and will deliver a copy of the notice to the Company. 

8. Effect on Other Agreements. 
 This
Agreement is the entire agreement between you and the Company with respect to the relationship contemplated by this Agreement and supersedes any earlier agreement, written or oral, with respect to the subject matter of this Agreement, including the
Prior Agreement other than Section 3(c) of the Prior Agreement and such other Sections and Sub-Sections of the Prior Agreement as are necessary to give effect to Sections 3(c) (including, but not limited to, Section 3(f) and the definition
of “Cause” in Section 5(d)(1) and “Good Reason” in Section 5(e)(1)). In entering into this Agreement, no party has relied on or made any representation, warranty, inducement, promise or understanding that is not in this
Agreement. This Agreement shall have no effect on any equity award agreements with respect to grants made to you prior to the Effective Date, including without limitation pursuant to Section 3(c) of the Prior Agreement, which shall continue to
be governed by their terms. 

  
 11 

 9. Assignment/Successor. 

(a) Assignment by You. You may not assign this Agreement without the Company’s consent. Also, except as required by law, your right
to receive payments or benefits under this Agreement may not be subject to execution, attachment, levy or similar process. 
 (b)
Successor in Interest. In the event of a Change in Control or other reorganization of the Company, the provisions of this Agreement shall be binding upon and inure to the benefit of the entity surviving or resulting from such Change in
Control or reorganization. The Company shall require such surviving entity to assume and agree (in writing) to perform this Agreement in the same manner and to the same extent that the Company would have been required to perform it if no such
succession had taken place. 
 10. Disputes. 

(a) Employment Matter. This Section 10 applies to any controversy or claim between you and the Company arising out of or relating
to or concerning this Agreement or any aspect of your employment with the Company or the termination of that employment (together, an “Employment Matter”). 

(b) Mandatory Arbitration. Subject to the provisions of this Section 10, any Employment Matter will be finally settled
by arbitration in the County of New York administered by the American Arbitration Association under its Commercial Arbitration Rules then in effect.  

(c) Limitation on Damages. You and the Company agree that there will be no punitive damages payable as a result of any
Employment Matter and agree not to request punitive damages.  
 (d) Injunctions and Enforcement of Arbitration Awards. You or
the Company may bring an action or special proceeding in a state or federal court of competent jurisdiction sitting in the County of New York to enforce any arbitration award under this Section 10. Also, the Company may bring such an action or
proceeding, in addition to its rights under this Section 10 and whether or not an arbitration proceeding has been or is ever initiated, to temporarily, preliminarily or permanently enforce any part of Section 7. You agree that
(1) your violating any part of Section 7 would cause damage to the Group that cannot be measured or repaired, (2) the Company therefore is entitled to an injunction, restraining order or other equitable relief restraining any actual
or threatened violation of those Sections, (3) no bond will need to be posted for the Company to receive such an injunction, order or other relief, (4) no proof will be required that monetary damages for violations of those Sections would
be difficult to calculate and that remedies at law would be inadequate and (5) the General Counsel of the Company is irrevocably appointed as your agent for service of process in connection with any such action or proceeding (the General
Counsel will promptly advise you of any such service of process). 
 (e) Jurisdiction and Choice of Forum. You and the
Company irrevocably submit to the exclusive jurisdiction of any state or federal court located in the County of New York over any Employment Matter that is not otherwise arbitrated or resolved according to this Section 10. This includes any
action or proceeding to compel arbitration or to enforce an arbitration award. Both you and the Company (1) acknowledge that the forum stated herein has a reasonable relation to this Agreement and to the relationship between you and the Company
and that the submission to the forum will apply even if the forum chooses to apply non-forum law, (2) waive, to the extent permitted by law, any objection to personal jurisdiction or to the laying of venue of any action or proceeding covered by
this subsection in the forum stated herein, (3) agree not to commence any such action or proceeding in any forum other than the forum stated in this subsection and (4) agree that, to the extent permitted by law, a final and non-appealable
judgment in any such action or proceeding in any such court will be conclusive and binding on you and the Company. However, nothing in this Agreement precludes you or the Company from bringing any action or proceeding in any court for the purpose of
enforcing the provisions of this Section 10. 

  
 12 

 (f) Waiver of Jury Trial. To the extent permitted by law, you and the Company
waive any and all rights to a jury trial with respect to any Employment Matter.  
 (g) Governing Law. This Agreement
will be governed by and construed in accordance with the law of the State of New York applicable to contracts made and to be performed entirely within that State.  

(h) Costs. You and the Company shall each pay its own legal fees and expenses incurred as a result of any Employment Matter;
provided however, that the Company will reimburse you for the reasonable legal fees of your counsel (i) to the extent that you prevail on any material issue in dispute or (ii) if the dispute occurs within two (2) years
following a Change in Control as long as you are not acting in bad faith; provided, further, that the Company shall reimburse you for the reasonable legal fees of your counsel in connection with the preparation of this Agreement in an amount
not to exceed $25,000 (for which you shall submit a bill promptly following the date hereof and which the Company shall reimburse no later than December 31, 2014). 

11. General Provisions. 
 (a)
Construction.  
 (1) References to the following terms have the meanings stated: 

(A) To Sections are to sections of this Agreement unless otherwise stated. 

(B) To any contract (including this Agreement) are to the contract as amended, modified, supplemented or replaced from
time to time. 
 (C) To any law, rule or regulation are to the statute, rule or regulation as amended,
modified, supplemented or replaced from time to time (and, in the case of laws, include any rules and regulations promulgated under the statute) and to any section of any law, rule or regulation include any successor to the section. 

(D) To any governmental authority include any successor to the governmental authority. 

(E) To any plan include any programs, practices and policies. 

(F) To any entity include any corporation, limited liability company, partnership, association, business trust and
similar organization and include any governmental authority. 
 (G) To any affiliate of any entity are to any person
or other entity directly or indirectly controlling, controlled by or under common control with the first entity. 
 (2) The
various headings in this Agreement are for convenience of reference only and in no way define, limit or describe the scope or intent of any provisions or Sections of this Agreement. 

(3) Unless the context requires otherwise, (A) words describing the singular number include the plural and vice
versa, (B) words denoting any gender include all genders and (C) the words “include”, “includes” and “including” will be deemed to be followed by the words “without
limitation.” 
 (4) It is your and the Company’s intention that this Agreement not be construed more strictly with
regard to you or the Company. 
 (b) Withholding. You and the Company will treat all payments to you under this Agreement as
compensation for services. Accordingly, the Company may withhold from any payment any taxes that are required to be withheld under any law, rule or regulation. 

  
 13 

 (c) Severability. If any provision of this Agreement is found by any court of competent
jurisdiction (or legally empowered agency) to be illegal, invalid or unenforceable for any reason, then (1) the provision will be amended automatically to the minimum extent necessary to cure the illegality or invalidity and permit enforcement
and (2) the remainder of this Agreement will not be affected. In particular, if any provision of Section 7 is so found to violate law or be unenforceable because it applies for longer than a maximum permitted period or to greater than a
maximum permitted area, it will be automatically amended to apply for the maximum permitted period and maximum permitted area. 
 (d) No
Set-off or Mitigation. Your and the Company’s respective obligations under this Agreement will not be affected by any set-off, counterclaim, recoupment or other right you or any member of the Group may have against each other or anyone
else. You do not need to seek other employment or take any other action to mitigate any amounts owed to you under this Agreement, and those amounts will not be reduced if you do obtain other employment (except as this Agreement specifically states).

 (e) Notices. All notices, requests, demands and other communications under this Agreement must be in writing and will be deemed
given (1) on the business day sent, when delivered by hand or facsimile transmission (with confirmation) during normal business hours, (2) on the business day after the business day sent, if delivered by a nationally recognized overnight
courier or (3) on the third business day after the business day sent if delivered by registered or certified mail, return receipt requested, in each case to the following address or number (or to such other addresses or numbers as may be
specified by notice that conforms hereto: 
 If to you, to the most recent address on file with the Company. 

If to the Company: 

Voya Financial, Inc. 

230 Park Avenue 

13th Floor 

New York, N.Y. 10169 

Attention: Bridget M. Healy, EVP and Chief Legal Officer 

Facsimile: 212-309-8364 

(f) Consideration. This Agreement is in consideration of the mutual covenants contained in it. You and the Company acknowledge the
receipt and sufficiency of the consideration to this Agreement and intend this Agreement to be legally binding. 
 (g) Amendments and
Waivers. Any provision of this Agreement may be amended or waived but only if the amendment or waiver is in writing and signed, in the case of an amendment, by you and the Company or, in the case of a waiver, by the party that would have
benefited from the provision waived. Except as this Agreement otherwise provides, no failure or delay by you or the Company to exercise any right or remedy under this Agreement will operate as a waiver, and no partial exercise of any right or remedy
will preclude any further exercise. 
 (h) Third Party Beneficiaries. This Agreement will be binding on, inure to the benefit of and
be enforceable by the parties, your heirs and personal representatives and the Company’s successors and assigns. This Agreement does not confer any rights, remedies, obligations or liabilities to any entity or person other than you and the
Company, your heirs and personal representatives and the Company’s permitted successors and assigns. 
 (i) Section 409A.
This Agreement is intended to comply with the requirements of Section 409A of the Code and the regulations and guidance promulgated thereunder (“Section 409A of the Code”) and shall in all respects be administered in accordance with
Section 409A of the Code. In the event that any provision of this Agreement or other agreement or award referenced herein is mutually agreed by the parties to be in violation of Section 409A of the Code, the parties shall cooperate
reasonably to attempt to amend or modify this Agreement (or other agreement or award) in order to avoid a violation of Section 409A of the Code while attempting to preserve the economic intent of the applicable provision. Notwithstanding
anything to the contrary in this Agreement or elsewhere, if you are a “specified employee” as determined pursuant to Section 409A of the Code as of the date of your “separation from service” (within the meaning of Treas.
Reg. 1.409A-1(h)) and if any payment or benefit 

  
 14 

 
provided for in this Agreement or otherwise both (x) constitutes a “deferral of compensation” within the meaning of Section 409A of the Code and (y) cannot be paid or
provided in the manner otherwise provided without subjecting you to “additional tax”, interest or penalties under Section 409A of the Code, then any such payment or benefit that is payable during the first six months following your
“separation from service” shall be paid or provided to you in a cash lump-sum on the first business day of the seventh calendar month following the month in which your “separation from service” occurs. Any payment or benefit due
upon a termination of your employment that represents a “deferral of compensation” within the meaning of Section 409A of the Code shall only be paid or provided to you upon a “separation from service”. For purposes of this
Agreement, all rights to payments and benefits hereunder will be treated as rights to receive a series of separate payments and benefits to the fullest extent allowed by Section 409A of the Code and each installment of any amount to be paid in
two or more installments shall be treated as a separate payment for purposes of Section 409A of the Code. Except as otherwise expressly provided herein, to the extent any expense reimbursement or the provision of any in-kind benefit under this
Agreement is determined to be subject to Section 409A of the Code, the amount of any such expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year shall not affect the expenses eligible for
reimbursement in any other taxable year (except for any life-time or other aggregate limitation applicable to medical expenses), in no event shall any expenses be reimbursed after the last day of the calendar year following the calendar year in
which you incurred such expenses, and in no event shall any right to reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit. 

(j) Counterparts; Effective Date. This Agreement may be executed in counterparts, each of which will constitute an original and all of
which, when taken together, will constitute one agreement. This Agreement is entered into as of the date hereof, and shall be deemed effective as of the Effective Date. 

[The next page is the signature page.] 

  
 15 

 
			
	Very truly yours,
	
	 VOYA FINANCIAL., INC.

		
	By:	 	/s/ J. Barry Griswell
	Name:	 	J. Barry Griswell
	Title:	 	 Chairman of the Compensation and
 Benefits
Committee of the Board of
 Directors

 AGREED AND ACKNOWLEDGED: 
  

	
	
	/s/ Rodney O. Martin, Jr.
	 Rodney O. Martin, Jr., Chairman and Chief

    Executive Officer

  
 16 

 Appendix I 

Retirement Equity Vesting Examples 
 Assumptions

  

	 	1.	Grants are made on March 1 of each year 

  

	 	2.	The PSU performance period begins on January 1 and we have used a 36 month calendar years cycle for vesting pro-rating (from January 1-December 31) 

 

	 	3.	The RSU vesting is on the anniversary of the grant, with full vesting after 36 months from grant 

  

	 	4.	The 2015 PSU grants has two tranches—a third with a two-year performance period and two-thirds with a three year performance period; subsequent PSU grants have a three-year performance period 

 

	 	5.	Percentages are rounded to the closest whole number 

 Example #1: Retirement on June 30, 2015 

 

							
	 Type of Grant
	  	 Portion of Total Award
	  	Vesting %	 	 Comments

	 2015 PSU Grant (55% of LTI)
	  		  		 	
	 Tranche 1
	  	33% of PSUs	  	100%	 	6 months service from start of performance period plus 24 additional months = 30 months on a 24 month cycle, so award is fully vested
	 Tranche 2
	  	67% of PSUs	  	0%	 	6 months service plus 24 additional months = 30 months on a 36 month cycle, so award does not vest
	 Total 2015 PSU Grant
	  		  	33%	 	Weighted average of two tranches
	 2015 RSUs (45% of LTI)
	  		  		 	
	 Tranche 1
	  	33% of RSUs	  	100%	 	4 months service from grant date plus 24 months = 28 months on a 12 month cycle, so fully vested
	 Tranche 2
	  	33% of RSUs	  	100%	 	4 months service from grant date plus 24 months = 28 months on a 24 month cycle, so fully vested
	 Tranche 3
	  	33% of RSUs	  	0%	 	4 months service from grant date plus 24 months = 28 months on a 36 month cycle, so does not vest
	 Total 2015 RSU Grant
	  		  	67%	 	Weighted average of three tranches

  
 Appendix I - 1

 Example #2: Retirement on June 30, 2016 

 

							
	 Type of Grant
	  	 Portion of Total Award
	  	Vesting %	 	 Comments

	 2015 PSU Grant (55% of annual LTI)
	  		  		 	
	 Tranche 1
	  	33% of PSUs	  	100%	 	18 months service from start of performance period plus 24 additional months = 42 months on a 24 month cycle, so award is fully vested
	 Tranche 2
	  	67% of PSUs	  	100%	 	18 months service plus 24 additional months = 42 months on a 36 month cycle, so award is fully vested
	 Total 2015 PSU Grant
	  		  	100%	 	Weighted average of two tranches
	 2015 RSUs (45% of annual LTI)
	  		  		 	
	 Tranche 1
	  	33% of RSUs	  	100%	 	16 months service from grant date with 12 month vesting, so this tranche would have already vested
	 Tranche 2
	  	33% of RSUs	  	100%	 	16 months service from grant date plus 24 months = 40 months credit on a 24 month cycle, so fully vested
	 Tranche 3
	  	33% of RSUs	  	100%	 	16 months from grant date plus 24 months = 40 months on a 36 month cycle, so fully vested
	 Total 2015 RSU Grant
	  		  	100%	 	Weighted average of three tranches
	 2016 PSU Grant (55% of LTI)
	  		  	0%	 	6 months service from start of performance period plus 24 months = 30 months on a 36 month cycle, so not vested
	 2016 RSUs (45% of LTI)
	  		  		 	
	 Tranche 1
	  	33% of RSUs	  	100%	 	4 months service from grant date plus 24 months = 28 months on a12 month cycle, so fully vested
	 Tranche 2
	  	33% of RSUs	  	100%	 	4 months service from grant date plus 24 months = 28 months on a 24 month cycle, so fully vested
	 Tranche 3
	  	33% of RSUs	  	0%	 	4 months service from grant date plus 24 months = 28 months on a 36 month cycle, so does not vest
	 Total 2016 RSU Grant
	  		  	67%	 	Weighted average of three tranches

  
 Appendix I - 2

 Example #3: Retirement on June 30, 2017 

 

							
	 Type of Grant
	  	 Portion of Total Award
	  	Vesting %	 	 Comments

	 2015 PSU Grant (55% of annual LTI)
	  		  		 	
	 Tranche 1
	  	33% of PSUs	  	100%	 	Would have already vested on March 1, 2017
	 Tranche 2
	  	67% of PSUs	  	100%	 	30 months of service from start of performance period plus 24 additional months = 54 months on a 36 month cycle, so award fully vests
	 Total 2015 PSU Grant
	  		  	100%	 	Weighted average of two tranches
	 2015 RSUs (45% of annual LTI)
	  		  		 	
	 Tranche 1
	  	33% of RSUs	  	100%	 	Would have already vested on March 1, 2016
	 Tranche 2
	  	33% of RSUs	  	100%	 	Would have already vested on March 1, 2017
	 Tranche 3
	  	33% of RSUs	  	100%	 	28 months of service from grant date plus 24 additional months = 52 months on a 36 month cycle, so award fully vests
	 Total 2015 RSU Grant
	  		  	100%	 	Weighted average of three tranches
	 2016 PSU Grant (55% of LTI)
	  		  	100%	 	18 months service from start of performance period plus 24 months = 42 months on a 36 month cycle, so fully vested
	 2016 RSUs (45% of LTI)
	  		  		 	
	 Tranche 1
	  	33% of RSUs	  	100%	 	Would have already vested on March 1, 2016
	 Tranche 2
	  	33% of RSUs	  	100%	 	16 months of service from grant date plus 24 additional months = 40 months on a 24 month cycle, so fully vested
	 Tranche 3
	  	33% of RSUs	  	100%	 	16 months of service from grant date plus 24 additional months = 40 months on a 36 month cycle, so fully vested
	 Total 2016 RSU Grant
	  		  	100%	 	Weighted average of three tranches
	 2017 PSU Grant (55% of LTI)
	  		  	83%	 	6 months of service from the start of the performance period plus 24 additional months = 30 months on a 36 month cycle = 79% vested (30/36)
	 2017 RSUs (45% of LTI)
	  		  		 	
	 Tranche 1
	  	33% of RSUs	  	100%	 	4 months service from grant date plus 24 additional months = 28 months on a 12 month cycle, so fully vested
	 Tranche 2
	  	33% of RSUs	  	100%	 	4 months service from grant date plus 24 additional months = 28 months on a 24 month cycle, so fully vested
	 Tranche 3
	  	33% of RSUs	  	78%	 	4 months of service from grant date plus 24 additional months = 28 months on a 36 month cycle, so 78% vested (28/36)
	 Total 2016 RSU Grant
	  		  	93%	 	Weighted average of three tranches

  
 Appendix I - 3

 ANNEX A 

RELEASE AGREEMENT 
 In exchange
for good and valuable consideration, including for receiving payment of separation benefits pursuant to your Employment Agreement as of December [ ], with Voya Financial, Inc. (the “Agreement”), less applicable taxes and withholdings, you
agree to release certain claims that you may have against Voya Financial, Inc. (“Company”) and its affiliates and agents as set forth below. 

By signing this Release Agreement (“Release”), you give up important rights, and we recommend that you discuss it with your
attorney. Even if you choose not to discuss it with your attorney, you must review the Release carefully, and make sure that you understand the meaning and the effect of the language. 

1. In consideration of the receipt of the separation payments and benefits under Section 6 of the Agreement, the receipt and sufficiency
of which is hereby acknowledged, I, Rodney O. Martin, Jr., for and on behalf of myself, my descendants, dependents, heirs, executors, administrators, trustees, legal representatives and permitted assigns (“Employee Releasors”) fully
and completely waive, release and acquit the Company and its past, present and future parents, subsidiaries and affiliates and each of their respective predecessors, successors and assigns, shareholders, directors, officers, partners, members,
managers, employees, trustees (in their official and individual capacities), representatives and agents, agents and consultants, independent contractors, attorneys and advisers, and each of their respective affiliates, successors and assigns
(collectively, the “Employer Releasees”), jointly and severally, from any and all claims, known or unknown, which the Employee Releasors have or may have against any of the Employer Releasees arising on or prior to the date of
execution of this Release and any and all liability which any of the Employer Releasees may have to Employee Releasors, whether denominated claims, demands, causes of action, complaints, obligations, damages, or liabilities arising from any and all
bases, however, denominated, including but not limited to, the Age Discrimination in Employment Act (“ADEA”), the Americans with Disabilities Act of 1990, the Family and Medical Leave Act of 1993, Title VII of the United States
Civil Rights Act of 1964, 42 U.S.C. § 1981, the Equal Pay Act, the Employee Retirement Income Security Act (“ERISA”), the Worker Adjustment and Retraining Notification Act (“WARN”), the Fair Labor Standards Act, Federal
Civil Rights Acts, the New York State Human Rights Law, including N.Y. Exec. Law § 296, the New York City Human Rights Law, including § 8-107 of the Administration Code and Charter of New York City, the New York Labor Law, any other
federal, state or local law and any workers’ compensation or disability claims under any such laws, and all contract and quasi-contract claims, claims for promissory estoppel or detrimental reliance, claims for wages, bonuses, incentive
compensation and severance allowances or entitlements, all claims for fraud, slander, libel, defamation, disparagement, intentional or negligent infliction of emotional distress, personal injury, negligence, breach of any implied covenant of good
faith and fair dealing or any other claim for damages or injury of any kind whatsoever, and all claims for monetary recovery, including, without limitation, attorneys’ fees, experts’ fees, medical fees or expenses, costs and disbursements.
This Release relates solely to claims arising from my relationship with the Company (and any predecessor or successor of the Company) as an employee or a director or as a result of the termination of any such relationship. I further agree that I
have not and will not file or, to the best of my ability, permit to be filed by an Employee Releasor or other person on my behalf any such claim. Notwithstanding the preceding sentence or any other provision of this Release, this Release is not
intended to interfere with my right to file a charge with the Equal Employment Opportunity Commission (the “EEOC”) in connection with any claim I believe I may have against the Company (or any predecessor or successor of the
Company). However, by executing this Release, I hereby waive the right to recover in any proceeding I may bring before the EEOC or any state or local civil or human rights commission or in any proceeding brought by the EEOC or any state or local
civil or human rights commission on my behalf. In addition, this Release is not intended to interfere with my right to challenge that my waiver of any and all ADEA claims pursuant to this Release is a knowing and voluntary waiver, notwithstanding my
specific representation that I have entered into this Release knowingly and voluntarily. This Release is for any relief, no matter how denominated, including, but not limited to, injunctive relief, wages, penalties, back pay, front pay, compensatory
damages, or punitive damages. This Release covers any actions, omissions, conduct, behavior, or events occurring prior to the date of my execution of this Release. This Release shall not apply to any obligation of the Company pursuant to this
Release or the Agreement, any rights in the nature of indemnification or director and officers liability insurance coverage which I may have with respect to claims against the Company or its past, current or future affiliates relating to or arising
out of my employment with the Company, any claims as a shareholder of the Company, or any vested benefit to which I am entitled under any employee benefit plans or to which I may be entitled by law. 

  
 Annex A-1 

 2. I understand that this Release does not constitute any admission by the Company of liability
or wrongdoing of any kind or of violation of any laws or regulations. I have entered into this Release voluntarily. 
 3. I acknowledge that
the payment(s) will be made within the time frames set forth in the Agreement. 
 4. To the extent not publicly disclosed pursuant to a
legally required filing, I agree to hold and maintain the terms of the payment to me of my separation amounts and benefits in confidence and not disclose them to any third party, except that I may disclose the same to my spouse and to my legal and
financial advisors for purposes of obtaining professional assistance, and as otherwise required by law, regulatory or governmental authority or as reasonably appropriate in connection with any legal dispute. I and the Company understand and agree
that confidentiality is a material term of the payment and this Release. 
 5. By my signature below, I acknowledge that I have read and
fully understand and accept the terms of this Release. I represent and agree that my signature is freely, voluntarily, and knowingly given. I also acknowledge that I have been provided a full opportunity to review and reflect on the terms of this
Release. I intend this Release to be legally binding. I understand that by executing this Release I am giving up certain rights which I (and any Employee Releasor) may have to sue or assert a claim against any of the Employer Releasees based on any
acts or omissions of the Employer Releasees up to the date of the signing of this Release. I further acknowledge that I have not been forced, coerced, subjected to duress or pressured in any manner whatsoever to sign this Release. 

6. I understand and acknowledge that I am being advised by the Company to consult with an attorney prior to signing this Release and have done
so to the extent I have deemed it necessary. My decision whether to sign this Release is my own voluntary decision made with full knowledge that the Company has advised me to consult with an attorney. I acknowledge that I have considered the terms
of this Release before I sign it. 
 7. I understand and acknowledge that I have received good and valuable consideration in exchange for my
execution of this Release. 
 8. I acknowledge that I have been given at least twenty-one (21) days to consider the terms of this
Release. I represent that I have consulted with an attorney to the extent that I deemed necessary prior to executing this Release. If I sign the Release before the end of the twenty-one (21) day period, it is because I have voluntarily and
knowingly decided to do so. I further acknowledge that I have received good and valuable consideration in exchange for my execution of this Release. 

9. I may rescind this Release within seven (7) days from the date that I execute this Release, and this Release will not become effective
or enforceable until after the seven (7) day rescission period has expired. If I choose to rescind this Release, I must deliver, by hand or by mail, a written rescission notice to the Executive Vice President and Chief Legal Officer, Voya
Financial, Inc. Legal Services at 230 Park Avenue, 13th Floor, New York, New York 10169, Fax No. (212) 309-8364, which must be received no later than 5:00 p.m., E.S.T. on the seventh (7th) day following the date of my execution of this Release. This Release will become effective upon the eighth (8th) day following the
date I execute this Release, unless rescinded by me in accordance with the provisions of this Paragraph. If delivered by mail, the rescission must be: (1) postmarked within the seven day period; (2) sent to the above address; and
(3) sent by certified mail return receipt requested. If the Release is rescinded, I am not eligible for any of the severance payments and benefits under the Agreement described above in this Release. 

10. Disputes. I agree that Section 10 of the Employment Agreement shall apply to any controversy or claim between me and
the Company arising out of or relating to or concerning this Release and such controversy or claim shall be treated as an “Employment Matter” (as defined therein) for purposes of such Section. 

12. Severability. I agree that the provisions of this Release are severable and if any part of this Release is found to be
unenforceable, or otherwise invalid by any court of competent jurisdiction, the other provisions of this Release will remain in full force and effect. Any provision of this Release held invalid or unenforceable only in part or degree will remain in
full force and effect to the extent not held invalid or unenforceable. 

  
 Annex A-2 

 13. Entire Agreement. I agree that this Release and the Agreement encompass the
entire agreement between the parties relating to the cessation of Employee’s services to the Company. Employee acknowledges that he has not relied on any representations, promises, or agreements of any kind except those expressly set forth in
this Release and the Agreement. 
  

					
			
	   
	 		 	  

	Name	 		 	Date
			
	Voya Financial, Inc.	 		 	
			
	   
	 		 	  

	Name	 		 	Date

  
 Annex A-3 

 ANNEX B 

RELEASE AGREEMENT 
 1. Pursuant
to this Release Agreement, on behalf of itself, its past, present and future parents, subsidiaries and affiliates and each of their respective predecessors, successors and assigns, shareholders, directors, officers, partners, members, managers,
employees, trustees (in their official and individual capacities), representatives and agents, agents and consultants, independent contractors, attorneys and advisers, and each of their respective affiliates, successors and assigns (collectively,
the “Employer Releasors”), Voya Financial, Inc. (the “Company”) hereby fully and completely waives, releases and acquits Rodney O. Martin, Jr. (the “Employee”), his descendants, dependents, heirs,
executors, administrators, trustees, legal representatives and permitted assigns and (collectively, the “Employee Releasees”), jointly and severally, from any and all claims, known or unknown, which the Employer Releasors have or
may have against any of the Employee Releasees arising on or prior to the date of execution of this Release and any and all liability which any of the Employee Releasees may have to the Employer Releasors, whether denominated claims, demands, causes
of action, complaints, obligations, damages, or liabilities, arising solely from the Employee’s relationship with the Company (and any predecessor or successor of the Company) as an employee or a director or as a result of the termination of
any such relationship. This Release Agreement shall not apply to any obligation of the Employee pursuant to Section 7 of his Employment Agreement as of December [ ], 2014, with the Company (the “Agreement”), any claims arising out of
any fraud established to have been committed by the Employee in connection with the conduct of the business of the Company or any of rights or obligations of the Company to recoup any compensation paid by the Company or any of its affiliates at any
time to the Employee to the extent such recoupment is required by applicable law or listing standards (including any Company policy implementing such listing standards). 

2. The Company understands that this Release Agreement does not constitute any admission by the Employee of liability or wrongdoing of any
kind or of violation of any laws or regulations. 
 3. To the extent not publicly disclosed pursuant to a legally required filing, the
Company agrees to hold and maintain the terms of the payment to the Employee of the Employee’s separation amounts and benefits under the Agreement in confidence and not disclose them to any third party, except that it may disclose the same to
its legal and financial advisors for purposes of obtaining professional assistance, and as otherwise required by law, regulatory or governmental authority or as reasonably appropriate in connection with any legal dispute. The Company and the
Employee understand and agree that confidentiality is a material term of the payment and this Release. 
 4. Disputes. The
Company agrees that Section 10 of the Employment Agreement shall apply to any controversy or claim between it and the Employee arising out of or relating to or concerning this Release and such controversy or claim shall be treated as an
“Employment Matter” (as defined therein) for purposes of such Section. 
 5. Severability. The Company agrees that
the provisions of this Release Agreement are severable and if any part of this Release Agreement is found to be unenforceable, or otherwise invalid by any court of competent jurisdiction, the other provisions of this Release Agreement will remain in
full force and effect. Any provision of this Release Agreement held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable. 

 

					
	Voya Financial, Inc.	 		 	
			
	   
	 		 	  

	Name	 		 	Date
			
	   
	 		 	  

	Name	 		 	Date

  
 Annex B-1EXHIIBIT 10.1

 

SECURITIES PURCHASE AGREEMENT

 

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 30, 2014, by and between Artec Global Media, Inc., a Nevada corporation, with headquarters located at 5536 S. Ft. Apache, #102, Las Vegas, NV 89148 (the “Company”), and LG Capital Funding, LLC., a New York Limited Liability Company, with its address at 1218 Union Street, Suite #2, Brooklyn, NY 11225 (the “Buyer”).

 

WHEREAS:

 

A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “1933 Act”);

 

B. Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement three 8% convertible notes of the Company, in the forms attached hereto as Exhibits A, B, and C in the aggregate principal amount of $165,375.00 (with each note being in the amount of $55,125.00 (together with any note(s) issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, the “Note”), convertible into shares of common stock, $0.001 par value per share, of the Company (the “Common Stock”), upon the terms and subject to the limitations and conditions set forth in such Note. The first of the two notes (the “First Note”) shall be paid for by the Buyer as set forth herein. The second note (the “Second Note”) shall be paid for by the Buyer as set forth herein, 90 days after the funding of (the “First Note”). The third note (the “Third Note”) shall be paid for by the issuance of an offsetting $52,500.00 secured note issued to the Company by the Buyer. The Third Note may not be converted until it has been paid for in cash and the Buyer note (the “Buyer Note”) has been paid.

 

C. The Buyer wishes to purchase, upon the terms and conditions stated in this Agreement, such principal amount of Note as is set forth immediately below its name on the signature pages hereto; and

 

NOW THEREFORE, the Company and the Buyer severally (and not jointly) hereby agree as follows:

 

1.  Purchase and Sale of Note.

 

a. Purchase of Note. On the Closing Date (as defined below), the Company shall issue and sell to the Buyer and the Buyer agrees to purchase from the Company such principal amount of Note as is set forth immediately below the Buyer’s name on the signature pages hereto.

 

______________

Company Initials

	 
	
1

	

  

b.  Form of Payment. On the Closing Date (as defined below), (i) the Buyer shall pay the purchase price for the Note to be issued and sold to it at the Closing (as defined below) (the “Purchase Price”) by wire transfer of immediately available funds to the Company, in accordance with the Company’s written wiring instructions, against delivery of the Note in the principal amount equal to the Purchase Price as is set forth immediately below the Buyer’s name on the signature pages hereto, and (ii) the Company shall deliver such duly executed Note on behalf of the Company, to the Buyer, against delivery of such Purchase Price.

 

c. Closing Date. The date and time of the issuance and sale of the first Note pursuant to this Agreement (the “Closing Date”) shall be on or about October 30, 2014, or such other mutually agreed upon time. The closing of the transactions contemplated by this Agreement (the “Closing”) shall occur on the Closing Date at such location as may be agreed to by the parties. Subsequent Closings shall occur as set forth on the schedule set forth on the signature page to this Agreement, provided that the Company is able to maintain the price and volume covenants ($1.00 per share and aggregate trading volume of $20,000 in 5 consecutive trading days) set forth in the Third Note at all times.

 

2.  Buyer’s Representations and Warranties. The Buyer represents and warrants to the Company that:

 

a. Investment Purpose. As of the date hereof, the Buyer is purchasing the Note and the shares of Common Stock issuable upon conversion of or otherwise pursuant to the Note, such shares of Common Stock being collectively referred to herein as the “Conversion Shares” and, collectively with the Note, the “Securities”) for its own account and not with a present view towards the public sale or distribution thereof, except pursuant to sales registered or exempted from registration under the 1933 Act; provided, however, that by making the representations herein, the Buyer does not agree to hold any of the Securities for any minimum or other specific term and reserves the right to dispose of the Securities at any time in accordance with or pursuant to a registration statement or an exemption under the 1933 Act.

 

b.  Accredited Investor Status. The Buyer is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D (an “Accredited Investor”).

 

c. Reliance on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance upon specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of the Buyer to acquire the Securities.

 

	 
	
2

	

  

d.  Information. The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue to be, furnished with all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities which have been requested by the Buyer or its advisors. The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue to be, afforded the opportunity to ask questions of the Company. Notwithstanding the foregoing, the Company has not disclosed to the Buyer any material nonpublic information and will not disclose such information unless such information is disclosed to the public prior to or promptly following such disclosure to the Buyer. Neither such inquiries nor any other due diligence investigation conducted by Buyer or any of its advisors or representatives shall modify, amend or affect Buyer’s right to rely on the Company’s representations and warranties contained in Section 3 below. The Buyer understands that its investment in the Securities involves a significant degree of risk. The Buyer is not aware of any facts that may constitute a breach of any of the Company's representations and warranties made herein. 

  

e. Governmental Review. The Buyer understands that no United States federal or state agency or any other government or governmental agency has passed upon or made any recommendation or endorsement of the Securities.

 

f. Transfer or Re-sale. The Buyer understands that (i) the sale or re-sale of the Securities has not been and is not being registered under the 1933 Act or any applicable state securities laws, and the Securities may not be transferred unless (a) the Securities are sold pursuant to an effective registration statement under the 1933 Act, (b) the Buyer shall have delivered to the Company, at the cost of the Buyer, an opinion of counsel that shall be in form, substance and scope customary for opinions of counsel in comparable transactions to the effect that the Securities to be sold or transferred may be sold or transferred pursuant to an exemption from such registration, which opinion shall be accepted by the Company, (c) the Securities are sold or transferred to an “affiliate” (as defined in Rule 144 promulgated under the 1933 Act (or a successor rule) (“Rule 144”)) of the Buyer who agrees to sell or otherwise transfer the Securities only in accordance with this Section 2(f) and who is an Accredited Investor, (d) the Securities are sold pursuant to Rule 144, or (e) the Securities are sold pursuant to Regulation S under the 1933 Act (or a successor rule) (“Regulation S”), and the Buyer shall have delivered to the Company, at the cost of the Buyer, an opinion of counsel that shall be in form, substance and scope customary for opinions of counsel in corporate transactions, which opinion shall be accepted by the Company; (ii) any sale of such Securities made in reliance on Rule 144 may be made only in accordance with the terms of said Rule and further, if said Rule is not applicable, any re-sale of such Securities under circumstances in which the seller (or the person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the 1933 Act) may require compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC thereunder; and (iii) neither the Company nor any other person is under any obligation to register such Securities under the 1933 Act or any state securities laws or to comply with the terms and conditions of any exemption thereunder (in each case). Notwithstanding the foregoing or anything else contained herein to the contrary, the Securities may be pledged as collateral in connection with a bona fide margin account or other lending arrangement.

 

	 
	
3

	

  

g.  Legends. The Buyer understands that the Note and, until such time as the Conversion Shares have been registered under the 1933 Act may be sold pursuant to Rule 144 or Regulation S without any restriction as to the number of securities as of a particular date that can then be immediately sold, the Conversion Shares may bear a restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer of the certificates for such Securities):

 

	
 

	
 “NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

	
 

  

The legend set forth above shall be removed and the Company shall issue a certificate without such legend to the holder of any Security upon which it is stamped, if, unless otherwise required by applicable state securities laws, (a) such Security is registered for sale under an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to Rule 144 or Regulation S without any restriction as to the number of securities as of a particular date that can then be immediately sold, or (b) such holder provides the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable transactions, to the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act, which opinion shall be accepted by the Company so that the sale or transfer is effected. The Buyer agrees to sell all Securities, including those represented by a certificate(s) from which the legend has been removed, in compliance with applicable prospectus delivery requirements, if any. In the event that the Company does not accept the opinion of counsel provided by the Buyer with respect to the transfer of Securities pursuant to an exemption from registration, such as Rule 144 or Regulation S, within 2 business days, it will be considered an Event of Default under the Note.

 

h.  Authorization; Enforcement. This Agreement has been duly and validly authorized. This Agreement has been duly executed and delivered on behalf of the Buyer, and this Agreement constitutes a valid and binding agreement of the Buyer enforceable in accordance with its terms.

 

i. Residency. The Buyer is a resident of the jurisdiction set forth immediately below the Buyer’s name on the signature pages hereto.

 

	 
	
4

	

  

3.  Representations and Warranties of the Company. The Company represents and warrants to the Buyer that:

 

a. Organization and Qualification. The Company and each of its subsidiaries, if any, is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate and other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated and conducted.

 

b.  Authorization; Enforcement. (i) The Company has all requisite corporate power and authority to enter into and perform this Agreement, the Note and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance with the terms hereof and thereof, (ii) the execution and delivery of this Agreement, the Note by the Company and the consummation by it of the transactions contemplated hereby and thereby (including without limitation, the issuance of the Note and the issuance and reservation for issuance of the Conversion Shares issuable upon conversion or exercise thereof) have been duly authorized by the Company’s Board of Directors and no further consent or authorization of the Company, its Board of Directors, or its shareholders is required, (iii) this Agreement has been duly executed and delivered by the Company by its authorized representative, and such authorized representative is the true and official representative with authority to sign this Agreement and the other documents executed in connection herewith and bind the Company accordingly, and (iv) this Agreement constitutes, and upon execution and delivery by the Company of the Note, each of such instruments will constitute, a legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms.

 

c. Issuance of Shares. The Conversion Shares are duly authorized and reserved for issuance and, upon conversion of the Note in accordance with its respective terms, will be validly issued, fully paid and non-assessable, and free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders of the Company and will not impose personal liability upon the holder thereof.

 

d.  Acknowledgment of Dilution. The Company understands and acknowledges the potentially dilutive effect to the Common Stock upon the issuance of the Conversion Shares upon conversion of the Note. The Company further acknowledges that its obligation to issue Conversion Shares upon conversion of the Note in accordance with this Agreement, the Note is absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests of other shareholders of the Company.

 

	 
	
5

	

  

e. No Conflicts. The execution, delivery and performance of this Agreement, the Note by the Company and the consummation by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance and reservation for issuance of the Conversion Shares) will not (i) conflict with or result in a violation of any provision of the Certificate of Incorporation or By-laws, or (ii) violate or conflict with, or result in a breach of any provision of, or constitute a default (or an event which with notice or lapse of time or both could become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture, patent, patent license or instrument to which the Company or any of its subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations and regulations of any self-regulatory organizations to which the Company or its securities are subject) applicable to the Company or any of its subsidiaries or by which any property or asset of the Company or any of its subsidiaries is bound or affected (except for such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually or in the aggregate, have a material adverse effect). All consents, authorizations, orders, filings and registrations which the Company is required to obtain pursuant to the preceding sentence have been obtained or effected on or prior to the date hereof. The Company is not in violation of the listing requirements of the OTC Markets (the “OTC MARKETS”) and does not reasonably anticipate that the Common Stock will be delisted by the OTC MARKETS in the foreseeable future, nor are the Company’s securities “chilled” by FINRA. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

 

f. Absence of Litigation. There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

 

g.  Acknowledgment Regarding Buyer’ Purchase of Securities. The Company acknowledges and agrees that the Buyer is acting solely in the capacity of arm’s length purchasers with respect to this Agreement and the transactions contemplated hereby. The Company further acknowledges that the Buyer is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement and the transactions contemplated hereby and any statement made by the Buyer or any of its respective representatives or agents in connection with this Agreement and the transactions contemplated hereby is not advice or a recommendation and is merely incidental to the Buyer’ purchase of the Securities. The Company further represents to the Buyer that the Company’s decision to enter into this Agreement has been based solely on the independent evaluation of the Company and its representatives.

 

h.  No Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would require registration under the 1933 Act of the issuance of the Securities to the Buyer. The issuance of the Securities to the Buyer will not be integrated with any other issuance of the Company’s securities (past, current or future) for purposes of any shareholder approval provisions applicable to the Company or its securities.

 

	 
	
6

	

  

i. Title to Property. The Company and its subsidiaries have good and marketable title in fee simple to all real property and good and marketable title to all personal property owned by them which is material to the business of the Company and its subsidiaries, in each case free and clear of all liens, encumbrances and defects except such as are described in Schedule 3(i) or such as would not have a material adverse effect. Any real property and facilities held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as would not have a material adverse effect.

 

j. Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange Commission.

 

k.  Breach of Representations and Warranties by the Company. If the Company breaches any of the representations or warranties set forth in this Section 3, and in addition to any other remedies available to the Buyer pursuant to this Agreement, it will be considered an Event of default under the Note.

 

4.  COVENANTS.

 

a. Expenses. At the Closing, the Company shall reimburse Buyer for expenses incurred by them in connection with the negotiation, preparation, execution, delivery and performance of this Agreement and the other agreements to be executed in connection herewith (“Documents”), including, without limitation, reasonable attorneys’ and consultants’ fees and expenses, transfer agent fees, fees for stock quotation services, fees relating to any amendments or modifications of the Documents or any consents or waivers of provisions in the Documents, fees for the preparation of opinions of counsel, escrow fees, and costs of restructuring the transactions contemplated by the Documents. When possible, the Company must pay these fees directly, otherwise the Company must make immediate payment for reimbursement to the Buyer for all fees and expenses immediately upon written notice by the Buyer or the submission of an invoice by the Buyer. The Company’s obligation with respect to this transaction is to reimburse Buyer’ expenses shall be $2,500 in legal fees for the first note (and similar amounts for each additional note) which shall be deduced from each Note when funded.

 

b.  Listing. The Company shall promptly secure the listing of the Conversion Shares upon each national securities exchange or automated quotation system, if any, upon which shares of Common Stock are then listed (subject to official notice of issuance) and, so long as the Buyer owns any of the Securities, shall maintain, so long as any other shares of Common Stock shall be so listed, such listing of all Conversion Shares from time to time issuable upon conversion of the Note. The Company will obtain and, so long as the Buyer owns any of the Securities, maintain the listing and trading of its Common Stock on the OTC MARKETS or any equivalent replacement exchange, the Nasdaq National Market (“Nasdaq”), the Nasdaq SmallCap Market (“Nasdaq SmallCap”), the New York Stock Exchange (“NYSE”), or the American Stock Exchange (“AMEX”) and will comply in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the Financial Industry Regulatory Authority (“FINRA”) and such exchanges, as applicable. The Company shall promptly provide to the Buyer copies of any notices it receives from the OTC MARKETS and any other exchanges or quotation systems on which the Common Stock is then listed regarding the continued eligibility of the Common Stock for listing on such exchanges and quotation systems.

 

	 
	
7

	

  

c. Corporate Existence. So long as the Buyer beneficially owns any Note, the Company shall maintain its corporate existence and shall not sell all or substantially all of the Company’s assets, except in the event of a merger or consolidation or sale of all or substantially all of the Company’s assets, where the surviving or successor entity in such transaction (i) assumes the Company’s obligations hereunder and under the agreements and instruments entered into in connection herewith and (ii) is a publicly traded corporation whose Common Stock is listed for trading on the OTC MARKETS, Nasdaq, Nasdaq SmallCap, NYSE or AMEX.

 

d.  No Integration. The Company shall not make any offers or sales of any security (other than the Securities) under circumstances that would require registration of the Securities being offered or sold hereunder under the 1933 Act or cause the offering of the Securities to be integrated with any other offering of securities by the Company for the purpose of any stockholder approval provision applicable to the Company or its securities.

 

e. Right of Notice and Adjustment. While any Notes are outstanding, the Company shall grant the Buyer notice of any debt financings of $200,000 or under (a “Qualified Financing”) completed with any other parties. In addition, if the terms of any Qualified Financing are better than the terms offered herein with respect to OID, discount, lookback or interest rate, then the terms in the Notes offered herein shall be adjusted to match the more favorable terms set forth in the Qualified Financing.

 

f. Breach of Covenants. If the Company breaches any of the covenants set forth in this Section 4, and in addition to any other remedies available to the Buyer pursuant to this Agreement, it will be considered an event of default under the Note.

 

5.  Governing Law; Miscellaneous.

 

a. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this Agreement shall be brought only in the state courts of New York or in the federal courts located in the state and county of New York. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The Company and Buyer waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney's fees and costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in connection with this Agreement by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

	 
	
8

	

  

b.  Counterparts; Signatures by Facsimile. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. This Agreement, once executed by a party, may be delivered to the other party hereto by facsimile transmission of a copy of this Agreement bearing the signature of the party so delivering this Agreement.

 

c. Headings. The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation of, this Agreement.

 

d.  Severability. In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision hereof.

 

e. Entire Agreement; Amendments. This Agreement and the instruments referenced herein contain the entire understanding of the parties with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company nor the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may be waived or amended other than by an instrument in writing signed by the majority in interest of the Buyer.

 

f. Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such party shall have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be:

 

	 
	
9

	

  

	
If to the Company, to:

	
Artec Global Media, Inc.

	
5536 S. Ft. Apache, #102

	
Las Vegas, NV 89148

	
Attn: Caleb Wickman, CEO

	
 

	
If to the Buyer:

	
 

	
LG CAPITAL FUNDING, LLC

	
1218 Union Street, Suite #2

	
Brooklyn, NY 11225

	
Attn: Joseph Lerman, Manager

  

Each party shall provide notice to the other party of any change in address.

 

g.  Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns. Neither the Company nor the Buyer shall assign this Agreement or any rights or obligations hereunder without the prior written consent of the other. Notwithstanding the foregoing, the Buyer may assign its rights hereunder to any person that purchases Securities in a private transaction from the Buyer or to any of its “affiliates,” as that term is defined under the 1934 Act, without the consent of the Company.

 

h.  Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

i. Survival. The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall survive the closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Buyer. The Company agrees to indemnify and hold harmless the Buyer and all their officers, directors, employees and agents for loss or damage arising as a result of or related to any breach or alleged breach by the Company of any of its representations, warranties and covenants set forth in this Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as they are incurred.

 

j. Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

   

k.  No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party.

 

l. Remedies. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Buyer by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of this Agreement, that the Buyer shall be entitled, in addition to all other available remedies at law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach of this Agreement and to enforce specifically the terms and provisions hereof, without the necessity of showing economic loss and without any bond or other security being required.

 

	 
	
10

	

  

IN WITNESS WHEREOF, the undersigned Buyer and the Company have caused this Agreement to be duly executed as of the date first above written.

  

		ARTEC GLOBAL MEDIA, INC.	 
		 	 	 
	 	By:		 
		Name:	Caleb Wickman	 
		Title:	CEO	 

   

		LG CAPITAL FUNDING, LLC.	 
		 	 	 
	 	By:		 
		Name:	Joseph Lerman	 
		Title:	Manager

  

AGGREGATE SUBSCRIPTION AMOUNT:

 

	Aggregate Principal Amount of Note:	 	
$

	
165,375.00

	 

  

Aggregate Purchase Price: 

 

Note 1: $55,125.00 less OID of $2,625 less $2,500.00 in legal fees

 

Note 2: $55,125.00 less OID of $2,625 less $2,500.00 in legal fees and will be issued January 30, 2015

 

Note 3: $55,125.00 less OID of $2,625 less $2,500.00 in legal fees initially paid for with a full recourse note issued January 30, 2015 secured by $52,500 in cash with cash payment to be made on April 30, 2015 subject to the terms of the note

 

	 
	
11

	

  

EXHIBIT A

 

144 NOTE - $55,125

 

 

 

 

 

	 
	
12

	

  

EXHIBIT B

 

144 NOTE - $55,125 

 

 

 

 

 

	 
	
13

	

 

EXHIBIT C

 

BACK END NOTE 

$55,125 

 

 

 

 

 

 

14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}]]